Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Meininger

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Journal of Medical Genetics|June 26, 2010
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlationsStéphanie Millecamps, François Salachas, Cécile Cazeneuve, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosisWendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2021
Effect of familial clustering in the genetic screening of 235 French ALS familiesPhilippe Corcia, William Camu, Celine Brulard, et al.
Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 31, 2021
Impact of a frequent nearsplice <i>SOD1</i> variant in amyotrophic lateral sclerosis: optimising <i>SOD1</i> genetic screening for gene therapy opportunitiesFrançois Muratet, Elisa Teyssou, Aude Chiot, et al.
Biomedicines|March 29, 2023
The <i>HFE</i> p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with <i>SOD1</i> MutationsAntonio Canosa, Andrea Calvo, Gabriele Mora, et al.
Plos One|April 18, 2012
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALSFrank P Diekstra, Christiaan G J Saris, Wouter van Rheenen, et al.
Journal of Alzheimer'S Disease : JAD|December 21, 2012
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testingIsabelle Le Ber, Agnès Camuzat, Lena Guillot-Noel, et al.
Human Molecular Genetics|November 16, 2013
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosisAn Goris, Jessica van Setten, Frank Diekstra, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 23, 2022
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesiclesLaura Le Gall, William J Duddy, Cecile Martinat, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of Medical Genetics|June 26, 2010
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlationsStéphanie Millecamps, François Salachas, Cécile Cazeneuve, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosisWendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2021
Effect of familial clustering in the genetic screening of 235 French ALS familiesPhilippe Corcia, William Camu, Celine Brulard, et al.
Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 31, 2021
Impact of a frequent nearsplice <i>SOD1</i> variant in amyotrophic lateral sclerosis: optimising <i>SOD1</i> genetic screening for gene therapy opportunitiesFrançois Muratet, Elisa Teyssou, Aude Chiot, et al.
Biomedicines|March 29, 2023
The <i>HFE</i> p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with <i>SOD1</i> MutationsAntonio Canosa, Andrea Calvo, Gabriele Mora, et al.
Plos One|April 18, 2012
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALSFrank P Diekstra, Christiaan G J Saris, Wouter van Rheenen, et al.
Journal of Alzheimer'S Disease : JAD|December 21, 2012
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testingIsabelle Le Ber, Agnès Camuzat, Lena Guillot-Noel, et al.
Human Molecular Genetics|November 16, 2013
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosisAn Goris, Jessica van Setten, Frank Diekstra, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 23, 2022
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesiclesLaura Le Gall, William J Duddy, Cecile Martinat, et al.
Pageof 15